Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
March 8, 2021

Johnson & Johnson’s Covid-19 vaccine receives interim order authorisation in Canada

Johnson & Johnson has secured authorisation for its Covid-19 vaccine under interim order (IO) from Health Canada for emergency use.

Continue
Johnson & Johnson’s Covid-19 vaccine receives interim order authorisation from Health Canada. (Credit: Wilfried Pohnke from Pixabay)
February 10, 2021

USFDA approves EUA for bamlanivimab-etesevimab combo to treat Covid-19 patients

The EUA is based on the BLAZE-1 trial Phase 3 data announced on 26 January 2021. Credit: Tumisu from Pixabay
February 9, 2021

USFDA awards Breakthrough Therapy designation to Novartis’ asciminib

Medicines that are being assessed for critical conditions are granted BTD if early clinical evidence indicates significant improvement potential over available therapy. Credit: Vachagan Malkhasyan from Pixabay

Contracts

February 3, 2021

Ocugen signs agreement with Bharat Biotech to distribute Covid-19 vaccine in the US

Ocugen to distribute Bharat Biotech’s COVAXIN in the US. (Credit: Pixabay/torstensimon.)

Lilly to provide antibody therapies at Indiana hospitals for treating COVID-19

Sanofi to manufacture 125 million doses of Pfizer-BioNTech’s Covid-19 vaccine

Humanigen gains BARDA access to produce lenzilumab for treating Covid-19

Deals

Deals March 5, 2021

Amgen signs agreement to acquire Five Prime Therapeutics for $1.9bn

Pharmaceutical Business Review

WuXi AppTec acquires OXGENE to develop cell and gene therapy services

Sandoz to acquire GlaxoSmithKline’s cephalosporin antibiotics business

AstraZeneca signs LOI with IDT Biologika to boost Europe’s Covid-19 vaccine-making capability

Popular

  1. Takeda secures global rights to develop and commercialise soticlestat
  2. Merck enters multiple agreements for supply of Covid-19 medicines and vaccines
  3. Boehringer Ingelheim, Gubra to validate new Peptides for obesity
  4. EMA validates Pfizer and OPKO’s somatrogon marketing application for review
  5. Merck signs agreement to purchase Pandion Therapeutics

PRESS RELEASES

Softigel Launches the First Virtual Booth Experience Platform
Softigel Launches the First Virtual Booth Experience Platform
New Corporate Design Visualises Gerresheimer’s Strategic Orientation
New Corporate Design Visualises Gerresheimer’s Strategic Orientation
Gerresheimer AG extends CEO Dietmar Siemssen’s Contract by Five Years
Gerresheimer AG extends CEO Dietmar Siemssen’s Contract by Five Years
Gerresheimer Presents Strong Fourth Quarter
Gerresheimer Presents Strong Fourth Quarter
Gerresheimer Triveni receives award for its active customer management from the Indian industry association CII
Gerresheimer Triveni receives award for its active customer management from the Indian industry association CII

Suppliers

Whitepapers

Diazirines for Photoaffinity Labelling
Diazirines for Photoaffinity Labelling
Sulfoximines for Drug Design
Sulfoximines for Drug Design
About the Thermal Behavior of Acetylsalicylic Acid and Aspirin
About the Thermal Behavior of Acetylsalicylic Acid and Aspirin